Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease of 3243 A-->G mtDNA mutation from blood in MELAS syndrome: a longitudinal study.

S Rahman1, J Poulton, D Marchington

  • 1Metabolic Unit, Institute of Child Health, London, United Kingdom.

American Journal of Human Genetics
|November 22, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are women more susceptible than men to iatrogenic inferior alveolar nerve injury in dental implant surgery?

International journal of oral and maxillofacial surgery·2021
Same author

Correction to: Spectrum of movement disorders and neurotransmitter abnormalities in paediatric POLG disease.

Journal of inherited metabolic disease·2018
Same author

Spectrum of movement disorders and neurotransmitter abnormalities in paediatric POLG disease.

Journal of inherited metabolic disease·2018
Same author

Sci-Thur PM: YIS - 09: Development of a graphite probe calorimeter for absolute clinical dosimetry: Numerical design optimization, prototyping and experimental proof-of-concept.

Medical physics·2017
Same author

Sci-Sat AM: Brachy - 03: Feasibility study of the determination of absorbed dose to water using a fricke based system.

Medical physics·2017
Same author

Distribution and factors associated with salivary secretory leukocyte protease inhibitor concentrations.

Oral diseases·2016
Same journal

Bi-allelic missense variants in human GPN2 result in Perrault syndrome.

American journal of human genetics·2026
Same journal

Integrative analysis of gastric tissue transcriptomes and gastric cancer GWAS implicates candidate susceptibility genes.

American journal of human genetics·2026
Same journal

A transparent and generalizable deep-learning framework for genomic ancestry prediction.

American journal of human genetics·2026
Same journal

Data-driven RNA phenotyping captures genetically regulated dimensions of the transcriptome.

American journal of human genetics·2026
Same journal

Linkage disequilibrium and allelic heterogeneity explain variation in coronary artery disease risk at 9p21 across populations and reduced effect in Africans.

American journal of human genetics·2026
Same journal

Genome-wide association study and predictors of neonatal blood cell traits in Hispanic newborns.

American journal of human genetics·2026
See all related articles

Mitochondrial DNA (mtDNA) disease progression may be linked to mutant mtDNA changes. In MELAS patients, mutant mtDNA levels in blood decreased over time, suggesting selection against it in rapidly dividing cells.

Area of Science:

  • Genetics
  • Molecular Biology
  • Neurology

Background:

  • Mitochondrial DNA (mtDNA) diseases are often progressive, with changes in mutant mtDNA distribution hypothesized to drive this progression.
  • However, empirical data documenting these dynamic changes in mutant mtDNA levels over time are scarce.
  • Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes (MELAS) syndrome is a common mtDNA disorder.

Purpose of the Study:

  • To investigate the longitudinal changes in mutant mtDNA levels in patients with MELAS syndrome.
  • To determine if mutant mtDNA load changes over time in blood cells.

Main Methods:

  • Comparison of mutant mtDNA levels in blood DNA from Guthrie cards (at birth) and diagnostic samples (9-19 years later) from six MELAS patients.
  • Quantification of the 3243 A-->G mutant mtDNA using a solid-phase minisequencing technique.

Related Experiment Videos

Main Results:

  • A significant decline in the proportion of mutant mtDNA was observed in all six MELAS patients.
  • The reduction in mutant mtDNA load ranged from 12% to 29% over the study period.
  • Statistical analysis (paired t-test) confirmed the decline (P=.0015).

Conclusions:

  • Mutant mtDNA levels can decrease over time in the blood of MELAS patients.
  • These findings suggest a slow selection process against mutant mtDNA in rapidly dividing blood cells.
  • This supports the hypothesis that mtDNA dynamics contribute to the clinical course of mtDNA diseases.